PBYI peer analysis
Puma Biotechnology (PBYI) against its competitors: price, today's move, 1-year return and market value side by side.
PBYI and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVBP ArriVent BioPharma | $13.52 | 10.58% | -29.68% | – |
| BDTX Black Diamond | $1.73 | 4.22% | -55.30% | $95.37M |
| CRDF Cardiff Oncology | $0.76 | -13.07% | -66.28% | $58.76M |
| MGNX MacroGenics | $2.33 | 4.95% | 64.58% | $141.41M |
| NBP NovaBridge Biosciences | $0.91 | -10.09% | -78.68% | – |
| NUVB Nuvation Bio | $4.19 | 0.00% | -14.02% | – |
| ONCY Oncolytics Biotech | $0.45 | 5.65% | -55.56% | $58.85M |
| ORIC Oric | $8.82 | 3.89% | -29.97% | $880.01M |
| TNGX Tango Therapeutics | $21.50 | 3.02% | 188.28% | – |
| VSTM Verastem | $8.40 | -10.45% | 1.53% | $1.14B |
| PBYI Puma Biotechnology | $7.96 | -18.51% | 65.12% | $504.33M |
- PBYI's peers: AVBP (ArriVent BioPharma), BDTX (Black Diamond), CRDF (Cardiff Oncology), MGNX (MacroGenics), NBP (NovaBridge Biosciences), NUVB (Nuvation Bio), ONCY (Oncolytics Biotech), ORIC (Oric).
Updated 2026-11-07 11:50 UTC